How Much Weight Can You Lose on Tirzepatide?
Tirzepatide is one of the most talked-about GLP-1 medications for weight loss, largely because of its clinical trial results. Here’s what the data actually shows, and what tends to affect where any one person lands.
What the clinical trial data shows
In the SURMOUNT-1 trial, published in the New England Journal of Medicine, adults taking tirzepatide lost an average of 16% to 22.5% of their body weight over 72 weeks, depending on dose - the highest, 15mg dose group averaged about 52 lbs lost, compared to a 5 lb loss in the placebo group. These are trial averages for tirzepatide, the active ingredient - not a guarantee for any individual, and Renlo’s compounded tirzepatide is not the branded product studied in the trial.
Why results vary from person to person
A few factors tend to influence how much weight someone loses:
- Dose. Higher doses in the trial were associated with greater average weight loss, and dosing is individualized and titrated gradually under provider supervision.
- Consistency. Tirzepatide is a once-weekly injection - missing doses or inconsistent timing can affect results.
- Starting point and body composition. Individual metabolic factors affect how anyone responds to any medication.
- Lifestyle factors. Nutrition and activity levels work alongside the medication, not instead of it.
What to actually expect week to week
Weight loss with tirzepatide tends to be gradual rather than immediate, building over weeks and months as your dose increases. Early weeks often involve dose adjustment and managing side effects like nausea before steady progress becomes noticeable. See what to expect with GLP-1 weight loss for a broader timeline.
Getting started with Renlo
Renlo’s compounded tirzepatide is $269/month on the monthly plan, or $233/month on the 3-month plan, prescribed after a licensed provider reviews your intake. See tirzepatide pricing.
This article is for general educational purposes only and is not medical advice. Clinical results reflect tirzepatide, the active ingredient, from the SURMOUNT-1 trial (New England Journal of Medicine) - not a guarantee. Renlo’s compounded tirzepatide is not the branded product studied in this trial, and individual results vary based on your body, dose, and adherence.
Frequently asked questions
How much weight can you lose on tirzepatide?
In the SURMOUNT-1 clinical trial, adults taking the 15mg dose of tirzepatide lost an average of 52 lbs (22.5% of body weight) over 72 weeks, compared to a 5 lb loss with placebo. Individual results vary based on dose, body, and adherence.
How fast does tirzepatide weight loss happen?
Weight loss with tirzepatide is typically gradual, building over months as your dose is titrated up under provider supervision, not a rapid initial drop.
Does everyone lose the same amount of weight on tirzepatide?
No. Results vary significantly based on starting dose, how your body responds, consistency, and lifestyle factors. Clinical trial averages describe a population, not a guarantee for any individual.